Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Apr 25, 2019 3:27pm
149 Views
Post# 29671123

RE:RE:RE:RE:Price

RE:RE:RE:RE:Price
peasoupfog wrote: CCAbbott, Any comment on the scenario I fear - late receipt of new Rights Shares while the people who get theirs early panic sell into a declining stock price, and the Investments Houses selling Short when the Rights offering Closes to drop the price so they can cover when Rights Shares received.?? Isnt that really plausible?

peasoupfog  yes, all the scenario you described are quite possible.  However, I try to look at it as an long-term investor, not traders who are much better at trading short-term volatility, arbritrage, short-selling etc.

After refinancing, the finance of Prometic is now re-set to a much more positive position (regardless how we got here). 

If the potential catalysts (2 Lazard deals, BLA re-submission, Nasdaq listing etc) do materialized as mentioned in April 1 Q4 2018 report, then it's very likely that the sp will recover from the current level, i.e.post refinancing/rights offers (25B shares@1.521 cents=market cap of $380M).

I'm not sure that the sp will go down as low as 1.521 cents post rights offer.  That will mean a higher market cap than 380M.  However, I hope that you see my point.

For any investor who decide to take part in the rights offer and whose time frame allows them to stay a bit longer than an immediate/complete exit, I think that the near to medium term (2-3 yrs) may present a more optimistic outlook than the current situation.  However, always keep an eye on the cash position to watch out for the next cash raise (i.e. dilution).

Bullboard Posts